Sort
40,608 grants matching “prostate cancer”
Aligning financial incentives to promote rational use of active surveillance for prostate cancer
$559,381Vahakn B Shahinian · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
Collaborative genomic alterations and transcriptional control in prostate cancer
$559,319Christopher E Barbieri · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · CA
The Role of Fgf Signaling in Vertebrate Development
$559,198Mark B Lewandoski · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Genetics of Prostate Cancer Susceptibility
$559,051Fred Hutchinson Cancer Research Center · R01 · FY2004 · CA
TARGETING NEUROENDOCRINE DIFFERENTIATION FOR PROSTATE CANCER RADIOSENSITIZATION
$558,983Purdue University · · FY2013 · Department of the Army
Cancer Genetic Markers of Susceptibility
$558,955Stephen J Chanock · Division Of Cancer Epidemiology And Genetics · ZIA · FY2023 · CA
Design, Develop, Validate, and Implement Biomarkers for Clinical Investigations
$558,923Liang Cao · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA
A new technique to make 68Ga-labeled pharmaceuticals widely available for clinical use
$558,907Joseph Reginald Osborne · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA
Oncogenic Met Signaling in Urologic Malignancies
$558,896Donald Bottaro · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Northwest Community Clinical Oncology Program
$558,820Lauren Colman · Tacoma General Hospital · U10 · FY2007 · CA
Tele-based Psychosocial Intervention for Symptom Management & HRQOL in Men Living
$558,816Frank J Penedo · Northwestern University At Chicago · R01 · FY2012 · CA
EVALUATING THE POTENTIAL OF ADIPOSE TISSUE-DERIVED MSCS AS ANTICANCER GENE DELIVERY VEHICLES TO BONE-METASTASIZED PROSTATE CANCER
$558,750The Administrators Of Tulane Educational Fund · · FY2009 · Department of the Army
MECHANISM OF ACTION OF AC-PSCN-NH3, A NOVEL COMPOUND THAT INHIBITS PROSTATE CANCER RECURRENCE AND METASTASIS
$558,731University Of Delaware · · FY2008 · Department of Defense
Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance
$558,718Antonio Fojo · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Novel Approaches Targeting B7-H3 in Castration-resistant Prostate Cancer
$558,663Di Zhao · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Development of Risk and Early Detection Biomarker for Small Cell Lung Cancer
$558,611Samir M Hanash · University Of Tx Md Anderson Can Ctr · U01 · FY2017 · CA
NUCLEAR MATRIX PROTEINS IN DISPARITY OF PROSTATE CANCER
$558,588The Administrators Of Tulane Educational Fund · · FY2009 · Department of the Army
"Statistical Methods for Genetic Epidemiology"
$558,584Alice S Whittemore · Stanford University · R01 · FY2011 · CA
Data Science Core
$558,537Ming Li · University Of Southern California · P30 · FY2023 · CA
Comorbid Disease in Women with Primary Ovarian Insufficiency
$558,419Corrine K Welt · Utah State Higher Education System--University Of Utah · R01 · FY2025 · HD
INHIBITION OF THE ADNROGEN RECEOPTOR AMINO-TERMINAL DOMAIN BY A SMALL MOLECULE AS TREATMENT FOR CSTRATE RESISTANCE PROSTATE CANCER
$558,408University Of Washington · · FY2011 · Department of Defense
Collaborative genomic alterations and transcriptional control in prostate cancer
$558,408Christopher E Barbieri · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · CA
Early clinial trials for Angelica herbal supplements for prostate cancer interception
$558,295Junxuan Lu · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2024 · CA
Adaptive Percutaneous Prostate Interventions using Sensorized Needle
$558,291Junichi Tokuda · Brigham And Women'S Hospital · R01 · FY2020 · CA
Mitochondrial Dynamics in RPE Homeostasis and Disease
$558,273Scott M Plafker · Oklahoma Medical Research Foundation · R01 · FY2020 · EY